Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1496201 TEL AVIV, L3

Position in TRVI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,306,890
+$2,458,725 QoQ
Shares Held
499,029
-13.1% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#53
of 216 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Derivatives in TRVI

reported options exposure · as of Sep 30, 2025
CallValue
$1,182,180
CallShares
129,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,413,848 across 71 Biotechnology names. TRVI ranks #12 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,306,890 499,029
2026-03-31 $6,848,165 574,029
2025-12-31 $7,493,645 598,534
2025-09-30 $1,182,180 129,200
2025-09-30 $5,892,206 643,957
2025-06-30 $4,375,764 799,957